Geographic · Current Income Tax Expense Benefit
Other — Current Income Tax Expense Benefit
Roivant Sciences Other — Current Income Tax Expense Benefit remained flat by 0.0% to -$6.75K in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Other — Current Income Tax Expense Benefit shows a downward trend with a -53.8% CAGR.
Analysis
StatementSegment
CategoryProfitability
SignalContext dependent
VolatilityVolatile
First reportedQ2 2020
Last reportedQ1 2026
Rolls up toIncome Tax
How to read this metric
A tax benefit signals a reduction in tax liability, often due to losses, while an expense indicates taxable income generated by the segment.
Detailed definition
This metric reflects the current income tax liability or benefit attributable specifically to the 'Other' business segme...
Peer comparison
Comparable to segment-level tax provisions found in the tax footnotes of diversified corporate entities.
Metric ID:
roiv_segment_other_current_income_tax_expense_benefitHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $592.00K | -$122.00K | -$310.00K | $0.00 | -$27.00K |
| YoY Change | — | -120.6% | -154.1% | +100.0% | — |
Range-$310.00K – $592.00K
CAGR-53.8%
Avg YoY Growth-58.2%
Median YoY Growth-120.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's other — current income tax expense benefit?
- Roivant Sciences (ROIV) reported other — current income tax expense benefit of -$6.75K in Q1 2026.
- What is the long-term trend for Roivant Sciences's other — current income tax expense benefit?
- Over 4 years (2021 to 2025), Roivant Sciences's other — current income tax expense benefit has grown at a -53.8% compound annual growth rate (CAGR), from $592.00K to -$27.00K.
- What does other — current income tax expense benefit mean?
- The actual income tax cost or tax credit associated with the company's non-core business segment for the current period.